オンコリスバイオファーマの株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2021/11/01 | 613 | 629 | 612 | 627 | +12 | +2% | 450,300 |
2021/10/29 | 628 | 632 | 615 | 615 | -17 | -2.7% | 544,600 |
2021/10/28 | 670 | 680 | 628 | 632 | -38 | -5.7% | 1,269,800 |
2021/10/27 | 653 | 699 | 622 | 670 | +53 | +8.6% | 4,368,700 |
2021/10/26 | 605 | 631 | 605 | 617 | +14 | +2.3% | 951,000 |
2021/10/25 | 665 | 675 | 601 | 603 | -97 | -13.9% | 2,576,300 |
2021/10/22 | 686 | 730 | 682 | 700 | +6 | +0.9% | 6,189,400 |
2021/10/21 | 694 | 694 | 694 | 694 | -150 | -17.8% | 63,100 |
2021/10/20 | 844 | 844 | 844 | 844 | -300 | -26.2% | 48,800 |
2021/10/19 | 1,142 | 1,157 | 1,139 | 1,144 | +4 | +0.4% | 76,000 |
2021/10/18 | 1,159 | 1,160 | 1,128 | 1,140 | -19 | -1.6% | 111,300 |
2021/10/15 | 1,132 | 1,162 | 1,132 | 1,159 | +29 | +2.6% | 157,800 |
2021/10/14 | 1,121 | 1,145 | 1,106 | 1,130 | +16 | +1.4% | 128,300 |
2021/10/13 | 1,089 | 1,123 | 1,088 | 1,114 | +26 | +2.4% | 143,600 |
2021/10/12 | 1,091 | 1,103 | 1,070 | 1,088 | ±0 | ±0% | 128,300 |
2021/10/11 | 1,068 | 1,090 | 1,050 | 1,088 | +14 | +1.3% | 104,000 |
2021/10/08 | 1,050 | 1,081 | 1,050 | 1,074 | +27 | +2.6% | 83,000 |
2021/10/07 | 1,026 | 1,055 | 1,018 | 1,047 | +31 | +3.1% | 161,000 |
2021/10/06 | 1,046 | 1,055 | 1,008 | 1,016 | -15 | -1.5% | 237,600 |
2021/10/05 | 1,060 | 1,067 | 1,025 | 1,031 | -59 | -5.4% | 344,800 |
2021/10/04 | 1,105 | 1,115 | 1,073 | 1,090 | -27 | -2.4% | 265,900 |
2021/10/01 | 1,122 | 1,135 | 1,103 | 1,117 | -13 | -1.2% | 176,200 |
2021/09/30 | 1,157 | 1,166 | 1,123 | 1,130 | -53 | -4.5% | 321,200 |
2021/09/29 | 1,168 | 1,185 | 1,158 | 1,183 | -1 | -0.1% | 172,600 |
2021/09/28 | 1,192 | 1,193 | 1,175 | 1,184 | -12 | -1% | 105,200 |
2021/09/27 | 1,209 | 1,216 | 1,191 | 1,196 | -18 | -1.5% | 84,600 |
2021/09/24 | 1,175 | 1,218 | 1,172 | 1,214 | +46 | +3.9% | 160,900 |
2021/09/22 | 1,194 | 1,210 | 1,166 | 1,168 | -26 | -2.2% | 154,700 |
2021/09/21 | 1,164 | 1,256 | 1,162 | 1,194 | -25 | -2.1% | 196,100 |
2021/09/17 | 1,202 | 1,223 | 1,195 | 1,219 | +9 | +0.7% | 88,500 |
2021/09/16 | 1,240 | 1,242 | 1,201 | 1,210 | -34 | -2.7% | 199,900 |
2021/09/15 | 1,236 | 1,251 | 1,218 | 1,244 | +6 | +0.5% | 231,400 |
2021/09/14 | 1,263 | 1,283 | 1,235 | 1,238 | -33 | -2.6% | 161,500 |
2021/09/13 | 1,250 | 1,276 | 1,244 | 1,271 | +14 | +1.1% | 152,500 |
2021/09/10 | 1,264 | 1,264 | 1,238 | 1,257 | +4 | +0.3% | 137,600 |
2021/09/09 | 1,279 | 1,295 | 1,250 | 1,253 | -35 | -2.7% | 155,200 |
2021/09/08 | 1,285 | 1,302 | 1,273 | 1,288 | +5 | +0.4% | 139,600 |
2021/09/07 | 1,299 | 1,317 | 1,281 | 1,283 | -15 | -1.2% | 155,300 |
2021/09/06 | 1,275 | 1,307 | 1,271 | 1,298 | +19 | +1.5% | 155,700 |
2021/09/03 | 1,278 | 1,300 | 1,271 | 1,279 | -3 | -0.2% | 116,500 |
2021/09/02 | 1,286 | 1,322 | 1,282 | 1,282 | -34 | -2.6% | 196,200 |
2021/09/01 | 1,270 | 1,320 | 1,260 | 1,316 | +46 | +3.6% | 171,800 |
2021/08/31 | 1,299 | 1,316 | 1,264 | 1,270 | -28 | -2.2% | 196,300 |
2021/08/30 | 1,327 | 1,327 | 1,292 | 1,298 | -13 | -1% | 198,400 |
2021/08/27 | 1,278 | 1,315 | 1,270 | 1,311 | +31 | +2.4% | 204,900 |
2021/08/26 | 1,247 | 1,287 | 1,247 | 1,280 | +34 | +2.7% | 142,000 |
2021/08/25 | 1,239 | 1,263 | 1,227 | 1,246 | +7 | +0.6% | 113,200 |
2021/08/24 | 1,256 | 1,259 | 1,225 | 1,239 | ±0 | ±0% | 149,700 |
2021/08/23 | 1,228 | 1,254 | 1,221 | 1,239 | +36 | +3% | 126,600 |
2021/08/20 | 1,213 | 1,249 | 1,201 | 1,203 | -3 | -0.2% | 179,100 |
751~
800
件表示中 / 2679件
類似銘柄と比較する
現在ご覧いただいている「オンコリス」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
オンコリス | 70,300円 | +58.7% | - | 0.00% | - | 12.39倍 |
|
腫瘍溶解ウイルス技術使うがん治療薬柱に感染症薬も開発。導出先が神経疾患薬を米国治験中 |
大幸薬品 | 36,400円 | +11.1% | - | 0.00% | 33.21倍 | 2.26倍 |
|
止瀉薬「正露丸」で有名な大衆薬中堅。オーナー経営色。不振の「クレベリン」など事業再構築中 |
ヘリオス | 19,600円 | +395.9% | - | 0.00% | - | 5.45倍 |
|
iPS細胞、体性幹細胞を活用する再生医薬品バイオベンチャー。住友ファーマと共同開発も |
Chordia | 24,900円 | - | - | 0.00% | - | 4.08倍 |
|
RNA制御ストレスを標的とする低分子抗がん薬を開発中。開発品・研究者は武田にルーツ |
CANBAS | 88,700円 | - | - | 0.00% | - | 7.35倍 |
|
抗がん剤開発に特化した創薬ベンチャー。主力の膵臓がん治療薬候補は自社開発。導出も模索 |
市場注目の銘柄
チャート関連のコラム